Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−422 JPY
−2.09 B JPY
17.71 B JPY
1.37 M
About J FRONTIER CO LTD
Sector
Industry
Headquarters
Tokyo
Website
Founded
2008
ISIN
JP3386650000
FIGI
BBG011WWM7H2
J Frontier Co., Ltd. engages in the sale, manufacture, planning, and development of healthcare products. It operates through the following segments: Healthcare Sales, Healthcare Marketing, and Dispensing Pharmacies. The Healthcare Sales segment mainly manufactures and sells the 328 selection series of supplements and Kusuri no Kenko Nihondo. The Healthcare Marketing segment deals with the wholesale of supplements and sales promotion of products through casting, public relations events, and social networking services. The Dispensing Pharmacies segment dispenses pharmaceutical products. The company was founded in June 2008 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2934 is 1,225 JPY — it has decreased by −1.69% in the past 24 hours. Watch J FRONTIER CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange J FRONTIER CO LTD stocks are traded under the ticker 2934.
2934 stock has risen by 2.00% compared to the previous week, the month change is a −44.94% fall, over the last year J FRONTIER CO LTD has showed a −70.52% decrease.
2934 reached its all-time high on Sep 19, 2023 with the price of 5,830 JPY, and its all-time low was 1,082 JPY and was reached on Aug 5, 2024. View more price dynamics on 2934 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2934 stock is 4.57% volatile and has beta coefficient of 1.69. Track J FRONTIER CO LTD stock price on the chart and check out the list of the most volatile stocks — is J FRONTIER CO LTD there?
Today J FRONTIER CO LTD has the market capitalization of 6.19 B, it has decreased by −5.68% over the last week.
Yes, you can track J FRONTIER CO LTD financials in yearly and quarterly reports right on TradingView.
J FRONTIER CO LTD is going to release the next earnings report on Jan 10, 2025. Keep track of upcoming events with our Earnings Calendar.
2934 net income for the last quarter is −1.45 B JPY, while the quarter before that showed −351.01 M JPY of net income which accounts for −312.78% change. Track more J FRONTIER CO LTD financial stats to get the full picture.
No, 2934 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 315.00 employees. See our rating of the largest employees — is J FRONTIER CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. J FRONTIER CO LTD EBITDA is −171.61 M JPY, and current EBITDA margin is −0.95%. See more stats in J FRONTIER CO LTD financial statements.
Like other stocks, 2934 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade J FRONTIER CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So J FRONTIER CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating J FRONTIER CO LTD stock shows the strong sell signal. See more of J FRONTIER CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.